The supply chain for HRT is 'broken' and patients are being put at risk amid a shortage of common medicines, chemists warn

Industry leaders say they are regularly struggling to source hormone replacement therapies and drugs for ADHD, diabetes and epilepsy.

Related Keywords

William Pett ,A Department Of Health ,Association Of Independent Multiple Pharmacies ,Facebook ,Leyla Hannbeck ,Independent Multiple Pharmacies ,Stock Image ,Healthwatch England ,Social Care ,Dailymail ,Health ,Adhd ,Nhs ,Diabetes ,